OSTERTAG ERIC (Chief Executive Officer) sold 0.6% of their position (18.92K shares) of POSEIDA THERAPEUTICS, INC. on the open market
Open‑market sale worth $134.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 11/10/2021ACC: 0001209191-21-063934
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2020
-18.92K
Net shares
Net seller
$134.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
18.92K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−9.87K
Price / share
$7.09
Trade value
$70K
% of position
0.3%
11/8/2021
3.67M→3.66M
Common Stock
Indirect
Shares
−9.05K
Price / share
$7.09
Trade value
$64.17K
% of position
0.3%
11/8/2021
3.37M→3.36M
Total
Net shares
−18.92K
Net value
-$134.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/8/2021 | S · Sale | −9.87K | $7.09 | $70K | 0.3% | 3.67M | 3.66M |
| Common Stock Indirect | 11/8/2021 | S · Sale | −9.05K | $7.09 | $64.17K | 0.3% | 3.37M | 3.36M |
| Total | −18.92K | -$134.17K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
DirectShares owned696.42K
Common Stock
IndirectShares owned629.19K
Common Stock
IndirectShares owned160.70K
Common Stock
IndirectShares owned961.45K
Total
696.42K direct·1.75M indirect2.45M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 696.42K | Direct |
| Common Stock | 629.19K | Indirect |
| Common Stock | 160.70K | Indirect |
| Common Stock | 961.45K | Indirect |
| Total | 2.45M | 696.42K direct·1.75M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported